Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5973040> ?p ?o }
Showing triples 1 to 37 of
37
with 100 triples per page.
- Q5973040 subject Q8760205.
- Q5973040 subject Q8760254.
- Q5973040 abstract "The iPLEDGE program is a mandatory distribution program in the United States for isotretinoin (commonly sold under the trade names Roaccutane, Claravis, Absorica, Amnesteem, Myorisan, Sotret, or Zenatane), intended to prevent the use of the drug during pregnancy due to the high risk of birth defects (see Teratogenicity of isoretinoin). As of March 1, 2006, patients and their doctors and pharmacists are required by the U.S. Food and Drug Administration (FDA) to register and use a web site in order to receive this medication.".
- Q5973040 owner Q204711.
- Q5973040 wikiPageExternalLink accutane.htm.
- Q5973040 wikiPageExternalLink NEW01218.html.
- Q5973040 wikiPageExternalLink ucm234639.pdf.
- Q5973040 wikiPageExternalLink www.ipledgeprogram.com.
- Q5973040 wikiPageExternalLink isotretinoin-and-other-retinoids-during-pregnancy.aspx.
- Q5973040 wikiPageExternalLink 525664.
- Q5973040 wikiPageExternalLink www.ipledgeprogram.com.
- Q5973040 wikiPageWikiLink Q11995.
- Q5973040 wikiPageWikiLink Q1331070.
- Q5973040 wikiPageWikiLink Q1976740.
- Q5973040 wikiPageWikiLink Q204711.
- Q5973040 wikiPageWikiLink Q223569.
- Q5973040 wikiPageWikiLink Q287029.
- Q5973040 wikiPageWikiLink Q465697.
- Q5973040 wikiPageWikiLink Q727096.
- Q5973040 wikiPageWikiLink Q751572.
- Q5973040 wikiPageWikiLink Q79928.
- Q5973040 wikiPageWikiLink Q8452.
- Q5973040 wikiPageWikiLink Q8760205.
- Q5973040 wikiPageWikiLink Q8760254.
- Q5973040 name "iPLEDGE Program".
- Q5973040 owner Q204711.
- Q5973040 url www.ipledgeprogram.com.
- Q5973040 type CreativeWork.
- Q5973040 type WebPage.
- Q5973040 type Website.
- Q5973040 type Work.
- Q5973040 type Thing.
- Q5973040 type Q386724.
- Q5973040 comment "The iPLEDGE program is a mandatory distribution program in the United States for isotretinoin (commonly sold under the trade names Roaccutane, Claravis, Absorica, Amnesteem, Myorisan, Sotret, or Zenatane), intended to prevent the use of the drug during pregnancy due to the high risk of birth defects (see Teratogenicity of isoretinoin). As of March 1, 2006, patients and their doctors and pharmacists are required by the U.S.".
- Q5973040 label "IPLEDGE".
- Q5973040 homepage www.ipledgeprogram.com.
- Q5973040 name "iPLEDGE Program".